FOXO3 and breast cancer: To investigate the molecular basis of synergy in Class IV responses in BT-20 cells we assayed nuclear translocation of the FoxO3a transcription factor, which (i) is regulated by PI3K, MAPK, and ErbB signaling cascades, (ii) serves as measure of drug response at a single-cell level, and (iii) regulates key aspects of breast cancer physiology such as cell cycle arrest and apoptosis32–34.